Why is 11β-hydroxy steroid dehydrogenase type 1 facing the endoplasmic reticulum lumen?: Physiological relevance of the membrane topology of 11β-HSD1

被引:59
|
作者
Odermatt, A
Atanasov, AG
Balazs, Z
Schweizer, RAS
Nashev, LG
Schuster, D
Langer, T
机构
[1] Univ Bern, Dept Clin Res, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland
[2] Univ Innsbruck, Inst Pharm, A-6020 Innsbruck, Austria
关键词
glucocorticoid receptor; 11 beta-hydroxysteroid dehydrogenase; cortisone; 7-ketocholesterol; hexose-6-phosphate dehydrogenase; membrane topology;
D O I
10.1016/j.mce.2005.11.040
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
11 beta-Hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) is essential for the local activation of glucocorticoid receptors (GR). Unlike unliganded cytoplasmic GR, 11 beta-HSD1 is an endoplasmic reticulum (ER)-membrane protein with lumenal orientation. Cortisone might gain direct access to 11 beta-HSD1 by free diffusion across membranes, indirectly via intracellular binding proteins or, alternatively, by insertion into membranes. Membranous cortisol, formed by 11 beta-HSD1 at the ER-lumenal side, might then activate cytoplasmic GR or bind to ER-lumenal secretory proteins. Compartmentalization of 11 beta-HSD1 is important for its regulation by hexose-6-phosphate dehydrogenase (H6PDH), which regenerates cofactor NADPH in the ER lumen and stimulates oxoreductase activity. ER-lumenal orientation of 11 beta-HSD1 is also essential for the metabolism of the alternative substrate 7-ketocholesterol (7KC), a major cholesterol oxidation product found in atherosclerotic plaques and taken up from processed cholesterol-rich food. An 11 beta-HSD1 mutant adopting cytoplasmic orientation efficiently catalyzed the oxoreduction of cortisone but not 7KC, indicating access to cortisone from both sides of the ER-membrane but to 7KC only from the lumenal side. These aspects may be relevant for understanding the physiological role of 11 beta-HSD1 and for developing therapeutic interventions to control glucocorticoid reactivation. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 50 条
  • [31] Reduction of acyl glucuronidation in a series of acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors: the discovery of AZD6925
    Scott, James S.
    Barton, Peter
    Bennett, Stuart N. L.
    deSchoolmeester, Joanne
    Godfrey, Linda
    Kilgour, Elaine
    Mayers, Rachel M.
    Packer, Martin J.
    Rees, Amanda
    Schofield, Paul
    Selmi, Nidhal
    Swales, John G.
    Whittamore, Paul R. O.
    [J]. MEDCHEMCOMM, 2012, 3 (10) : 1264 - 1269
  • [32] 17β-Hydroxysteroid Dehydrogenase 3 (17β-HSD3), a Regulator of 11β-Hydroxysteroid Dehydrogenase 1 (11β-HSD1) Activity in Rat Leydig Cell.
    Latif, S. A.
    Ge, R.
    Sottas, C. M.
    Shen, M.
    Morris, D. J.
    [J]. ENDOCRINE REVIEWS, 2010, 31 (03)
  • [33] Development of 11β-HSD1 inhibitors for the treatment of type 2 diabetes
    Hale, Clarence
    Wang, Minghan
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (07) : 702 - 710
  • [34] Direct protein-protein interaction of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen
    Atanasov, Atanas G.
    Nashev, Lyubomir G.
    Gelman, Laurent
    Legeza, Balazs
    Sack, Ragna
    Portmann, Reto
    Odermatt, Alex
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2008, 1783 (08): : 1536 - 1543
  • [35] Nocturnal activity of 11β-hydroxy steroid dehydrogenase type 1 is increased in type 1 diabetic children
    Barat, P.
    Brossaud, J.
    Lacoste, A.
    Vautier, V.
    Nacka, F.
    Moisan, M. -P.
    Corcuff, J. -B.
    [J]. DIABETES & METABOLISM, 2013, 39 (02) : 163 - 168
  • [36] 11β-hydroxysteroid dehydrogenase type 1 (11-HSD-1) activities in patients with hypopituitarism
    Kobayashi, Y
    Tagawa, N
    Ikariko, N
    Imamura, T
    Higashide, T
    Mori, H
    Inada, H
    Yamano, T
    [J]. CLINICAL CHEMISTRY, 2005, 51 : A226 - A226
  • [37] Comparison of a homology model and the crystallographic structure of human 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) in a structure-based identification of inhibitors
    Laurence Miguet
    Ziding Zhang
    Maryse Barbier
    Martin G. Grigorov
    [J]. Journal of Computer-Aided Molecular Design, 2006, 20 : 67 - 81
  • [38] Radiosynthesis and evaluation of an 11-beta hydroxysteroid dehydrogenase-1 (11β-HSD1) PET ligand in rhesus monkey
    Li Wenping
    Joshi, Aniket
    Zeng Zhizhen
    O'Malley, Stacey S.
    Miller, Patricia J.
    Riffel, Kerry
    Purcell, Mona L.
    Gantert, Liza T.
    Eng, Waisi
    Krause, Stephen
    Williams, Mangay
    Balkovec, James M.
    Waddell, Sherman T.
    Cook, Jacquelynn J.
    Hamill, Terence G.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S293 - S293
  • [39] Comparison of a homology model and the crystallographic structure of human 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) in a structure-based identification of inhibitors
    Miguet, Laurence
    Zhang, Ziding
    Barbier, Maryse
    Grigorov, Martin G.
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2006, 20 (02) : 67 - 81
  • [40] Identification and optimisation of 3,3-dimethylazetidin-2-ones as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1)
    McCoull, William
    Augustin, Martin
    Blake, Caroline
    Ertan, Anne
    Kilgour, Elaine
    Krapp, Stephan
    Moore, Jane E.
    Newcombe, Nicholas J.
    Packer, Martin J.
    Rees, Amanda
    Revill, John
    Scott, James S.
    Selmi, Nidhal
    Gerhardt, Stefan
    Ogg, Derek J.
    Steinbacher, Stefan
    Whittamore, Paul R. O.
    [J]. MEDCHEMCOMM, 2014, 5 (01) : 57 - 63